FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill
(By Ed Silverman for ST A T) P fizer won a crucial battle in its quest to widen the market
Read More(By Ed Silverman for ST A T) P fizer won a crucial battle in its quest to widen the market
Read More(By Usha Lee McFarling for ST A T) S cientists on Monday will urge the Food and Drug Administration to
Read More(By Ike Swetlitz for ST A T) N ew York Attorney General Eric T. Schneiderman is investigating Mylan Pharmaceuticals for
Read More(By Ed Silverman for ST A T) In a closely watched decision, the California Supreme Court ruled 4-3 Monday that
Read MoreU.S. Food and Drug Administration (FDA) approved Novartis’s Sandoz drug Erelzi (biosimilar copy of Amgen’s Enbrel) on Tuesday but it
Read More(By Kelsey Harkness for The Daily Signal) Five states and a group of religiously-affiliated hospitals and physicians are suing the
Read More(By Phil Galewitz for Kaiser Health News) A year after paying nearly $1.5 billion to more than a third of
Read More(By Sharon Begley for ST A T) Beneath the technical and legal jargon in the latest documents filed in the
Read More(By Ed Silverman for ST A T) In the latest dust-up over the high cost of hepatitis C drugs, the
Read More(By Ed Silverman for ST A T) S upporters of a California ballot measure, which is designed to lower drug
Read More